Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Greil

Showing results (101-110 of 525) with videos related to

Pageof 53
Sort By:
Expert Review of Hematology|February 9, 2018
The multiple myeloma treatment landscape: international guideline recommendations and clinical practice in EuropeMichele Cavo, Evangelos Terpos, Joan Bargay, et al.
European Journal of Haematology|May 7, 2004
Quality of life of patients with chronic lymphocytic leukemia: results of a longitudinal investigation over 1 yrBernhard Holzner, Georg Kemmler, Martin Kopp, et al.
British Journal of Haematology|December 11, 2002
Histone deacetylase inhibitors potently repress CXCR4 chemokine receptor expression and function in acute lymphoblastic leukaemiaRoman Crazzolara, Karin Jöhrer, Ricky W Johnstone, et al.
Breast Cancer Research and Treatment|February 14, 2007
Fulvestrant ('Faslodex') in heavily pretreated postmenopausal patients with advanced breast cancer: single centre clinical experience from the compassionate use programmeBrigitte Mlineritsch, Oskar Psenak, Peter Mayer, et al.
BMC Bioinformatics|April 20, 2023
Validation of genetic variants from NGS data using deep convolutional neural networksMarc Vaisband, Maria Schubert, Franz Josef Gassner, et al.
World Journal of Gastroenterology|May 31, 2014
Targeted therapy in advanced metastatic colorectal cancer: current concepts and perspectivesFlorian Hohla, Thomas Winder, Richard Greil, et al.
Anticancer Research|September 16, 2016
Assessment of Pharmacokinetic Interaction Between Capecitabine and Cetuximab in Metastatic Colorectal Cancer PatientsVeronika Rachar, Martin Czejka, Marie Kitzmueller, et al.
BMC Cancer|January 5, 2018
Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie)Florian Huemer, Josef Thaler, Gudrun Piringer, et al.
British Journal of Haematology|July 26, 2014
Kasabach-Merritt phenomenon in hepatic angiosarcomaStefan Habringer, Ann Boekstegers, Lukas Weiss, et al.
Annals of Hematology|January 21, 2014
Lenalidomide in combination with vorinostat and dexamethasone for the treatment of relapsed/refractory peripheral T cell lymphoma (PTCL): report of a phase I/II trialGeorg Hopfinger, Thomas Nösslinger, Alois Lang, et al.
Pageof 53

Showing results (101-110 of 525) with videos related to

Sort By:
Pageof 53
Expert Review of Hematology|February 9, 2018
The multiple myeloma treatment landscape: international guideline recommendations and clinical practice in EuropeMichele Cavo, Evangelos Terpos, Joan Bargay, et al.
European Journal of Haematology|May 7, 2004
Quality of life of patients with chronic lymphocytic leukemia: results of a longitudinal investigation over 1 yrBernhard Holzner, Georg Kemmler, Martin Kopp, et al.
British Journal of Haematology|December 11, 2002
Histone deacetylase inhibitors potently repress CXCR4 chemokine receptor expression and function in acute lymphoblastic leukaemiaRoman Crazzolara, Karin Jöhrer, Ricky W Johnstone, et al.
Breast Cancer Research and Treatment|February 14, 2007
Fulvestrant ('Faslodex') in heavily pretreated postmenopausal patients with advanced breast cancer: single centre clinical experience from the compassionate use programmeBrigitte Mlineritsch, Oskar Psenak, Peter Mayer, et al.
BMC Bioinformatics|April 20, 2023
Validation of genetic variants from NGS data using deep convolutional neural networksMarc Vaisband, Maria Schubert, Franz Josef Gassner, et al.
World Journal of Gastroenterology|May 31, 2014
Targeted therapy in advanced metastatic colorectal cancer: current concepts and perspectivesFlorian Hohla, Thomas Winder, Richard Greil, et al.
Anticancer Research|September 16, 2016
Assessment of Pharmacokinetic Interaction Between Capecitabine and Cetuximab in Metastatic Colorectal Cancer PatientsVeronika Rachar, Martin Czejka, Marie Kitzmueller, et al.
BMC Cancer|January 5, 2018
Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie)Florian Huemer, Josef Thaler, Gudrun Piringer, et al.
British Journal of Haematology|July 26, 2014
Kasabach-Merritt phenomenon in hepatic angiosarcomaStefan Habringer, Ann Boekstegers, Lukas Weiss, et al.
Annals of Hematology|January 21, 2014
Lenalidomide in combination with vorinostat and dexamethasone for the treatment of relapsed/refractory peripheral T cell lymphoma (PTCL): report of a phase I/II trialGeorg Hopfinger, Thomas Nösslinger, Alois Lang, et al.
Pageof 53